Satyavrat Shukla

Satyavrat Shukla

Chief Executive Officer at SPERO THERAPEUTICS, INC.

Net worth: - $ as of 30/03/2024

52 year
Health Technology
Consumer Services
Commercial Services

Profile

Satyavrat Shukla is currently the President, Chief Executive Officer & Director at Spero Therapeutics, Inc. He previously worked as the Vice President & Global Head-Corporate Finance at Vertex Pharmaceuticals, Inc. from 2012 to 2019.
Before that, he was a Principal at Cornerstone Research, Inc. from 2003 to 2012.
In 2019, he served as the Chief Financial Officer & Executive Vice President at Alaunos Therapeutics, Inc. Mr. Shukla completed his undergraduate degree at Harvard University in 1993 and obtained an MBA from Yale University in 1999.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/03/2024 0 ( -.--% ) - $ 30/03/2024

Satyavrat Shukla active positions

CompaniesPositionStart
SPERO THERAPEUTICS, INC. Chief Executive Officer 31/07/2023
All active positions of Satyavrat Shukla

Former positions of Satyavrat Shukla

CompaniesPositionEnd
ALAUNOS THERAPEUTICS, INC. Director of Finance/CFO 30/12/2020
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 30/06/2019
Corporate Officer/Principal 31/12/2011
See the detail of Satyavrat Shukla's experience

Training of Satyavrat Shukla

Harvard University Undergraduate Degree
Yale University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Satyavrat Shukla's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

ALAUNOS THERAPEUTICS, INC.

Health Technology

SPERO THERAPEUTICS, INC.

Health Technology

Private companies1

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Satyavrat Shukla